Gilead Sciences, Inc. vs Prudential Financial Inc — how do they compare? Gilead Sciences, Inc. trades at $135.19 (market cap $168.35B), while Prudential Financial Inc trades at $122.19 (market cap $42.20B). The key difference: Gilead Sciences, Inc. is far larger — about 4× Prudential Financial Inc's market cap, and Prudential Financial Inc pays the higher dividend (4.58%). Which is the better fit depends on your goals.
| GILD | PRU | |
|---|---|---|
Market Cap | $168.35B | $42.20B |
Sector | Health | Financials |
52-Week High | $155.80 | $123.93 |
52-Week Low | $110.56 | $92.00 |
Enterprise Value | $191.42B | $70.98B |
Dividend Yield | 2.42% | 4.58% |
Trailing returns across standard periods
Latest headlines on both assets
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →